Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Non-Current Assets (2019 - 2025)

Korro Bio's Non-Current Assets history spans 7 years, with the latest figure at $31.1 million for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets fell 67.13% year-over-year to $31.1 million, compared with a TTM value of $253.2 million through Dec 2025, down 21.79%, and an annual FY2025 reading of $31.1 million, down 67.13% over the prior year.
  • Non-Current Assets for Q4 2025 was $31.1 million at Korro Bio, down from $63.3 million in the prior quarter.
  • The five-year high for Non-Current Assets was $94.7 million in Q4 2024, with the low at $3.8 million in Q3 2023.
  • Average Non-Current Assets over 5 years is $50.9 million, with a median of $48.4 million recorded in 2021.
  • Year-over-year, Non-Current Assets plummeted 89.01% in 2023 and then soared 2258.02% in 2024.
  • Tracing KRRO's Non-Current Assets over 5 years: stood at $50.6 million in 2021, then crashed by 67.08% to $16.7 million in 2022, then soared by 193.75% to $48.9 million in 2023, then skyrocketed by 93.54% to $94.7 million in 2024, then tumbled by 67.13% to $31.1 million in 2025.
  • Per Business Quant, the three most recent readings for KRRO's Non-Current Assets are $31.1 million (Q4 2025), $63.3 million (Q3 2025), and $77.8 million (Q2 2025).